UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
European regulations might be responsible for lower numbers of advanced therapy clinical trials running in…
Cambridge-based Mogrify has raised €14.5M to develop a technology that could allow scientists to transform…
Sheffield is one of the UK’s historic industrial bases. It also hosts the biotech Rinri…
Based in Cambridge, UK, Lightcast Discovery is developing microfluidics technology that automates cell screening experiments…
The German pharmaceutical company Grünenthal has licensed a donor cell therapy for chronic low back…
The Italian biotech Genenta Science has raised €13.2M in a private round to fund two…
The London-based life sciences investor 4BIO Capital has raised €45M in the first close of…
The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell…
An off-the-shelf cancer immunotherapy developed by the Swedish biotech Immunicum has eradicated kidney tumors in…
The US company Celgene has obtained options to three cancer immunotherapy programs from the German…
A research group at ETH Zurich, Switzerland, has made it possible to edit hundreds of…